Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials.
Ethan M BaschGita ThanarajasingamAmylou C DueckPublished in: Clinical trials (London, England) (2022)